Iright
BRAND / VENDOR: Biolegend

Biolegend, 109820, Pacific Blue™ anti-mouse CD45.2 Antibody, 100μg

CATALOG NUMBER: 109820
Precio habitual$0.99
/
Los gastos de envío se calculan en la pantalla de pagos.
  • In stock, ready to ship

  • Pedido pendiente, envío pronto

Este sitio está protegido por hCaptcha y se aplican la Política de privacidad de hCaptcha y los Términos del servicio.

Product Description

CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.
100μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Mouse
Immunogen: B10.S mouse thymocytes and splenocytes
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with Pacific Blue™ under optimal conditions.
Concentration: 0.5 mg/ml
Storage & Handling: The CD45.2 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.* Pacific Blue™ has a maximum emission of 455 nm when it is excited at 405 nm. Prior to using Pacific Blue™ conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses
Excitation Laser: Violet Laser (405 nm)
Application Notes: The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3.
Application References(PubMed link indicates BioLegend citation): Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block) Yakura H, et al. 1986. J. Immunol. 136:2729. (Block) Suzuki K, et al. 2000. Immunity 13:691. (IHC) Shen FW, et al. 1986. Immunogenetics 24:146. (IP) Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837. Pascal V, et al. 2007. J. Immunol. 179:1751. Burman AC, et al. 2007. Blood 110:1064. Kincaid EZ, et al. 2007. J. Immunol. 179:3187. Phan TG, et al. 2007. Nature Immunol. 8:992. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed Wen T, et al. 2013. PNAS. 110:6067. PubMed Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations: Valladao A, et al. 2016. J Immunol. 197(12):4541-4551. PubMed Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed Collin R, et al. 2020. J Immunol. 205:133. PubMed MacLean AJ, et al. 2022. Immunity. 55:718. PubMed Omer-Javed A, et al. 2022. Cell. 185:2248. PubMed Vukovic N, et al. 2022. J Biol Chem. 298:102153. PubMed Grégoire C, et al. 2022. Immunity. 55:1216. PubMed Lu Z, et al. 2022. Cell Rep. 41:111482. PubMed Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed Israelow B, et al. 2020. bioRxiv. . PubMed Gazit R, et al. 2014. J Exp Med. 211:1315. PubMed Lauterbach MA, et al. 2020. Immunity. 51(6):997-1011.e7.. PubMed Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed Otano I, et al. 2021. Nat Commun. 12:7296. PubMed Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed Pascal V, et al. 2007. J Immunol. 179:1751. PubMed Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed Yalamanoglu A, et al. 2021. Front Immunol. 627944:12. PubMed Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed Roufaiel M, et al. 2016. Nat Immunol. 10.1038/ni.3564. PubMed Wong J, et al. 2015. Elife. 3: 07839. PubMed Silva D, et al. 2011. Diabetes. 60:2102. PubMed Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed Keller CW, et al. 2020. Autophagy. 1:. PubMed Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed Park Y, et al. 2013. Cancer Res . 73:5669. PubMed Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed Qiu F, et al. 2022. J Cancer. 13:2893. PubMed Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed Lin G, et al. 2013. PLoS One. 8:e56014. PubMed Zhu Y, et al. 2015. Neurobiol Dis. 74:114. PubMed Mizraji* G, et al. 2013. J Vis Exp. 77: 50388. PubMed Tuttle KD, et al. 2020. Cell Rep. 33:108407. PubMed Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed Flommersfeld S, et al. 2021. Immunity. :. PubMed Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed Arsiwala T, et al. 2022. Int J Mol Sci. 23:. PubMed Goldman E, et al. 2021. Cells. 10:. PubMed Dewas C, et al. 2015. J Immunol. 194:1372. PubMed Thiriot A et al. 2017. BMC biology. 15(1):45 . PubMed Chen X, et al. 2019. Nat Commun. 4.421527778. PubMed Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed Kincaid E, et al. 2007. J Immunol. 179:3187. PubMed Patel S, et al. 2019. Viruses. 0.877083333. PubMed Chen X, et al. 2021. Cell Rep. 37:109991. PubMed Kren N, et al. 2020. Sci Rep. 10:7390. PubMed Chung L et al. 2018. Cell host & microbe. 23(2):203-214 . PubMed Pfefferlé M, et al. 2021. Front Immunol. 12:680855. PubMed Cohen M, et al. 2014. EMBO J. 33:2906. PubMed Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed Scholz F, et al. 2015. J Immunol. 195: 2335-2342. PubMed Yabas M, et al. 2016. PLoS One. 11: 0146774. PubMed Ma K, et al. 2022. iScience. 25:104347. PubMed Reddy Y 2009. Proc Natl Acad Sci U S A. 106:21689. PubMed Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed Udden SN et al. 2019. eLife. 8 pii: e40396. PubMed Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed Zeis P, et al. 2020. Immunity. 53:775. PubMed Chhatbar C et al. 2018. Cell reports. 25(1):118-129 . PubMed Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed Tullett KM, et al. 2020. Elife. 9:00. PubMed Wang E, et al. 2013. Proc Natl Acad Sci U S A. 110:3901. PubMed Müller A, et al. 2012. Immunity. 37:147. PubMed Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed Kratky W, et al. 2011. Proc Natl Acad Sci U S A. 108:17414. PubMed Zlotoff D, et al. 2010. Blood. 115:1897. PubMed Teijeira á, et al. 2020. Immunity. 52(5):856-871. PubMed Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed Nagalingam G, et al. 2017. J Immunol. 10.4049/jimmunol.1602069. PubMed Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed Vannini N, et al. 2016. Nat Commun. 7:13125. PubMed Hall JA, et al. 2020. Cell Metabolism. 32(4):665-675.e6. PubMed Zhu Y et al. 2017. The Journal of Neuroscience. 37(9):2362-2376 . PubMed Astuti Y, et al. 2017. Stem Cell Reports. 8(1):177-190. PubMed Jackson C, et al. 2016. Clin Cancer Res. 22: 1161 - 1172. PubMed Teijaro J, et al. 2014. Proc Natl Acad Sci U S A. 111:3799. PubMed Knier B, et al. 2018. Nat Immunol. 1.722916667. PubMed
RRID: AB_492873 (BioLegend Cat. No. 109819) AB_492872 (BioLegend Cat. No. 109820)
Structure: Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution: All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice
Function: Phosphatase, T and B cell activation
Ligand/Receptor: Galectin-1, CD2, CD3, CD4
Biology Area: Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family: CD Molecules
Antigen References: 1. Suzuki K, et al. 2000. Immunity 13:691.
Gene ID: 19264
UniProt: View information about CD45.2 on UniProt.org
Clone: 104
Regulatory Status: RUO
Other Names: Ly-5.2, LCA
Isotype: Mouse (SJL) IgG2a, κ


Order Guidelines

1. Price & Stock Available on Request. 📧Click to send email to: service@iright.com

2. Please DO NOT make payment before confirmation.

3. Minimum order value of $1,000 USD required.

Collaboration

Tony Tang

📧Email: Tony.Tang@iright.com

📱Mobile/WhatsApp/Wechat: +86-17717886924